Drug cost data suggest patient copays, compliance linked
In 2005, the top five therapeutic classes for prescribed drugs purchased by adults accounted for nearly two-thirds of total prescription drug expenses by adults, according to the Agency for Healthcare Research and Quality (AHRQ) in Rockville, MD. The AHRQ findings offer capitated provider organizations insights into prescription drug costs for the most widely used therapeutic classes, and suggest compliance issues for the most expensive drugs.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Hospitals Likely to Outsource ICD-10 at Launch
- IOM Identifies GME Problems, Calls for Finance Changes
- CMS Confirms ICD-10 Deadline
- Anatomy of 3 Health System Rebranding Efforts
- Premium Subsidy Fight Creating Uncertainty for Hospitals, Health Plans
- 2015 HIX Premium Hikes May Top 7%